Evidence map›Paper›PMID 24904654›Full record

ArticleArchives of medical science : AMS2014

Detection and significance of TregFoxP3(+) and Th17 cells in peripheral blood of non-small cell lung cancer patients.

Sha Li, Yan Li, Xun Qu, Xiaolin Liu, Jing Liang

Open access · goldAbstract read
In one paragraph

Article in Archives of medical science : AMS, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Targeting T regulatory (TCancer drug resistance (Alhambra, Calif.) · 2024
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Effect of TGF-β1 on blood CD4Experimental and therapeutic medicine · 2018
    Article
  13. Review
  14. [Th1/Th2 and Treg/Th17 cell balance in peripheral blood of patients with ovarian cancer].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2017
    Article
  15. Article
  16. Significant reduction of peripheral blood interleukin-35 and CD4Central-European journal of immunology · 2017
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Sha LiDepartment of Oncology, Qianfoshan Hospital, Shandong University, Jinan, P.R. China.
Yan LiDepartment of Oncology, Qianfoshan Hospital, Shandong University, Jinan, P.R. China.
Xun QuInstitute of Basic Medical Sciences and Key Laboratory of Cardiovascular Proteomics of Shandong Province, Qilu Hospital, Shandong University, Jinan, P.R. China.
Xiaolin LiuDepartment of Oncology, Qianfoshan Hospital, Shandong University, Jinan, P.R. China.
Jing LiangDepartment of Oncology, Qianfoshan Hospital, Shandong University, Jinan, P.R. China.
Shandong Provincial QianFoShan Hospital · CNQilu Hospital of Shandong University · CNShandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe aim of this study was to explore the relationships between TregFoxP3(+) cells and Th17 cells and occurrence of lung cancer. MATERIAL AND

methodsThe proportions of TregFoxP3(+) and Th17 cells, the expression of FoxP3 and RORγt mRNA, and the levels of related cell factors such as transforming growth factor-β (TGF-β), interleukin IL-17 (IL-17) and IL-23 were determined respectively by flow cytometry analysis, real-time-polymerase chain reaction (PCR), and ELISA in peripheral blood of 18 healthy people and 26 patients with non-small cell lung cancer (NSCLC).

resultsThe levels of TregFoxP3(+) and Th17, expression of FoxP3 and RORγt mRNA, and ratios of TregFoxP3(+)/Th17 and FoxP3/RORγt in peripheral blood with NSCLC were higher than those in healthy controls (p < 0.05). The proportion of Th17 cells from NSCLC patients was positively correlated with that of TregFoxP3(+) (r = 0.81, p < 0.05). The receiver-operating characteristic (ROC) curve demonstrates that the increased level of TregFoxP3(+)/Th17 in the peripheral blood may be a useful indicator in early diagnosis of non-small cell lung carcinoma. The TregFoxP3(+)/Th17 and FoxP3/RORγt levels for patients in stage IV were higher than those of patients in stages I, II, and III (p < 0.05). The levels of TGF-β, IL-17, and IL-23 were higher in NSCLC patients than those in healthy controls.

conclusionsThe results suggest that ratios of Treg/Th17 correlate with the stage of NSCLC.

Indexed as

carcinomanon-small cell lungRORγtTh17TregFoxP3+

Identifiers

PMID24904654
PMCPMC4042043
OpenAlexW2040040990

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.